-
1
-
-
84856487711
-
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010
-
Flegal K. M., Carroll M. D., Kit B. K., Ogden C. L. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA: 2012; 307 5 491 497
-
(2012)
JAMA
, vol.307
, Issue.5
, pp. 491-497
-
-
Flegal, K.M.1
Carroll, M.D.2
Kit, B.K.3
Ogden, C.L.4
-
2
-
-
0037048669
-
Prevalence and trends in obesity among US adults, 1999-2000
-
Flegal K. M., Carroll M. D., Ogden C. L., Johnson C. L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA: 2002; 288 14 1723 1727
-
(2002)
JAMA
, vol.288
, Issue.14
, pp. 1723-1727
-
-
Flegal, K.M.1
Carroll, M.D.2
Ogden, C.L.3
Johnson, C.L.4
-
3
-
-
33645523067
-
Prevalence of overweight and obesity in the United States, 1999-2004
-
Ogden C. L., Carroll M. D., Curtin L. R., McDowell M. A., Tabak C. J., Flegal K. M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA: 2006; 295 13 1549 1555
-
(2006)
JAMA
, vol.295
, Issue.13
, pp. 1549-1555
-
-
Ogden, C.L.1
Carroll, M.D.2
Curtin, L.R.3
McDowell, M.A.4
Tabak, C.J.5
Flegal, K.M.6
-
4
-
-
34247851021
-
The Epidemiology of Obesity
-
DOI 10.1053/j.gastro.2007.03.052, PII S0016508507005793
-
Ogden C. L., Yanovski S. Z., Carroll M. D., Flegal K. M. The epidemiology of obesity. Gastroenterology: 2007; 132 6 2087 2102 (Pubitemid 46693751)
-
(2007)
Gastroenterology
, vol.132
, Issue.6
, pp. 2087-2102
-
-
Ogden, C.L.1
Yanovski, S.Z.2
Carroll, M.D.3
Flegal, K.M.4
-
5
-
-
33747517955
-
The epidemiology of nonalcoholic fatty liver disease in adults
-
DOI 10.1097/01.mcg.0000168638.84840.ff, PII 0000483620060300100003
-
Clark J. M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol: 2006; 40 01 S5 S10 (Pubitemid 44309537)
-
(2006)
Journal of Clinical Gastroenterology
, vol.40
, Issue.SUPPL. 1
-
-
Clark, J.M.1
-
6
-
-
79957449923
-
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008
-
Younossi Z. M., Stepanova M., Afendy M., et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol: 2011; 9 6 524 530, e1, quiz e60
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, Issue.6
, pp. 524-530
-
-
Younossi, Z.M.1
Stepanova, M.2
Afendy, M.3
-
7
-
-
84866531658
-
Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese
-
Liu C. J. Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. J Gastroenterol Hepatol: 2012; 27 10 1555 1560
-
(2012)
J Gastroenterol Hepatol
, vol.27
, Issue.10
, pp. 1555-1560
-
-
Liu, C.J.1
-
9
-
-
63349106888
-
Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network
-
NASH Clinical Research NetworkA list of members of the Nonalcoholic Steatohepatitis Clinical Research Network can be found in the Appendix.
-
Brunt E. M., Kleiner D. E., Wilson L. A., et al. NASH Clinical Research NetworkA list of members of the Nonalcoholic Steatohepatitis Clinical Research Network can be found in the Appendix. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology: 2009; 49 3 809 820
-
(2009)
Hepatology
, vol.49
, Issue.3
, pp. 809-820
-
-
Brunt, E.M.1
Kleiner, D.E.2
Wilson, L.A.3
-
10
-
-
26044451626
-
Pathological features of NASH
-
Brunt E. M., Tiniakos D. G. Pathological features of NASH. Front Biosci: 2005; 10 1475 1484
-
(2005)
Front Biosci
, vol.10
, pp. 1475-1484
-
-
Brunt, E.M.1
Tiniakos, D.G.2
-
11
-
-
84857944399
-
Nonalcoholic fatty liver disease: Pathologic patterns and biopsy evaluation in clinical research
-
Kleiner D. E., Brunt E. M. Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin Liver Dis: 2012; 32 1 3 13
-
(2012)
Semin Liver Dis
, vol.32
, Issue.1
, pp. 3-13
-
-
Kleiner, D.E.1
Brunt, E.M.2
-
12
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
DOI 10.1002/hep.20701
-
Kleiner D. E., Brunt E. M., Van Natta M., et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology: 2005; 41 6 1313 1321 (Pubitemid 40770284)
-
(2005)
Hepatology
, vol.41
, Issue.6
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
Ferrell, L.D.7
Liu, Y.-C.8
Torbenson, M.S.9
Unalp-Arida, A.10
Yeh, M.11
McCullough, A.J.12
Sanyal, A.J.13
-
13
-
-
78651041767
-
The liver in obesity
-
Zelman S. The liver in obesity. AMA Arch Intern Med: 1952; 90 2 141 156
-
(1952)
AMA Arch Intern Med
, vol.90
, Issue.2
, pp. 141-156
-
-
Zelman, S.1
-
15
-
-
0019152816
-
Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease
-
Ludwig J., Viggiano T. R., McGill D. B., Oh B. J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc: 1980; 55 7 434 438 (Pubitemid 10057164)
-
(1980)
Mayo Clinic Proceedings
, vol.55
, Issue.7
, pp. 434-438
-
-
Ludwig, J.1
Viggiano, T.R.2
McGill, D.B.3
Ott, B.J.4
-
16
-
-
0025178612
-
The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years
-
Powell E. E., Cooksley W. G., Hanson R., Searle J., Halliday J. W., Powell L. W. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology: 1990; 11 1 74 80 (Pubitemid 20075105)
-
(1990)
Hepatology
, vol.11
, Issue.1
, pp. 74-80
-
-
Powell, E.E.1
Cooksley, W.G.E.2
Hanson, R.3
Searle, J.4
Halliday, J.W.5
Powell, L.W.6
-
19
-
-
84879606466
-
New horizons in hepatitis C antiviral therapy with direct-acting antivirals
-
Aghemo A., De Francesco R. New horizons in hepatitis C antiviral therapy with direct-acting antivirals. Hepatology: 2013; 58 1 428 438
-
(2013)
Hepatology
, vol.58
, Issue.1
, pp. 428-438
-
-
Aghemo, A.1
De Francesco, R.2
-
20
-
-
84879152382
-
A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1
-
Lawitz E., Poordad F., Kowdley K. V., et al. A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1. J Hepatol: 2013; 59 1 18 23
-
(2013)
J Hepatol
, vol.59
, Issue.1
, pp. 18-23
-
-
Lawitz, E.1
Poordad, F.2
Kowdley, K.V.3
-
21
-
-
84876582239
-
Treatment of chronic hepatitis C: Current and future
-
Pawlotsky J. M. Treatment of chronic hepatitis C: current and future. Curr Top Microbiol Immunol: 2013; 369 321 342
-
(2013)
Curr Top Microbiol Immunol
, vol.369
, pp. 321-342
-
-
Pawlotsky, J.M.1
-
22
-
-
84455189494
-
The era of direct-acting antivirals has begun: The beginning of the end for HCV
-
Vachon M. L., Dieterich D. T. The era of direct-acting antivirals has begun: the beginning of the end for HCV? Semin Liver Dis: 2011; 31 4 399 409
-
(2011)
Semin Liver Dis
, vol.31
, Issue.4
, pp. 399-409
-
-
Vachon, M.L.1
Dieterich, D.T.2
-
23
-
-
2442545703
-
Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis and Orthotopic Liver Transplantation
-
DOI 10.1111/j.1600-6143.2004.00432.x
-
Burke A., Lucey M. R. Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and orthotopic liver transplantation. Am J Transplant: 2004; 4 5 686 693 (Pubitemid 38637564)
-
(2004)
American Journal of Transplantation
, vol.4
, Issue.5
, pp. 686-693
-
-
Burke, A.1
Lucey, M.R.2
-
24
-
-
80053581540
-
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States
-
Charlton M. R., Burns J. M., Pedersen R. A., Watt K. D., Heimbach J. K., Dierkhising R. A. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology: 2011; 141 4 1249 1253
-
(2011)
Gastroenterology
, vol.141
, Issue.4
, pp. 1249-1253
-
-
Charlton, M.R.1
Burns, J.M.2
Pedersen, R.A.3
Watt, K.D.4
Heimbach, J.K.5
Dierkhising, R.A.6
-
25
-
-
77958155198
-
Current status and future of liver transplantation
-
Merion R. M. Current status and future of liver transplantation. Semin Liver Dis: 2010; 30 4 411 421
-
(2010)
Semin Liver Dis
, vol.30
, Issue.4
, pp. 411-421
-
-
Merion, R.M.1
-
26
-
-
77951874018
-
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis
-
Sanyal A. J., Chalasani N., Kowdley K. V., et al. NASH CRN. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med: 2010; 362 18 1675 1685
-
(2010)
N Engl J Med
, vol.362
, Issue.18
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
-
27
-
-
79953745343
-
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits
-
NASH CRN; GIANT Consortium; MAGIC Investigators; GOLD Consortium.
-
Speliotes E. K., Yerges-Armstrong L. M., Wu J., et al. NASH CRN; GIANT Consortium; MAGIC Investigators; GOLD Consortium. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet: 2011; 7 3 e1001324
-
(2011)
PLoS Genet
, vol.7
, Issue.3
-
-
Speliotes, E.K.1
Yerges-Armstrong, L.M.2
Wu, J.3
-
28
-
-
26844483363
-
The NIDDK Bariatric Surgery clinical Research Consortium (LABS)
-
LABS Consortium.
-
Belle S., Consortium L.; LABS Consortium. The NIDDK Bariatric Surgery clinical Research Consortium (LABS). Surg Obes Relat Dis: 2005; 1 2 145 147
-
(2005)
Surg Obes Relat Dis
, vol.1
, Issue.2
, pp. 145-147
-
-
Belle, S.1
Consortium, L.2
-
29
-
-
0037008087
-
Updated definitions of healthy ranges for serum alanine aminotransferase levels
-
Prati D., Taioli E., Zanella A., et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med: 2002; 137 1 1 10
-
(2002)
Ann Intern Med
, vol.137
, Issue.1
, pp. 1-10
-
-
Prati, D.1
Taioli, E.2
Zanella, A.3
-
30
-
-
33947398857
-
Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery
-
DOI 10.1016/j.soard.2007.01.006, PII S1550728907000718
-
Belle S. H., Berk P. D., Courcoulas A. P., et al. Longitudinal Assessment of Bariatric Surgery Consortium Writing Group. Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery. Surg Obes Relat Dis: 2007; 3 2 116 126 (Pubitemid 46444704)
-
(2007)
Surgery for Obesity and Related Diseases
, vol.3
, Issue.2
, pp. 116-126
-
-
Belle, S.H.1
Berk, P.D.2
Courcoulas, A.P.3
Flum, D.R.4
Miles, C.W.5
Mitchell, J.E.6
Pories, W.J.7
Wolfe, B.M.8
Yanovski, S.Z.9
-
31
-
-
68049123594
-
Perioperative safety in the longitudinal assessment of bariatric surgery
-
Longitudinal Assessment of Bariatric Surgery (LABS) Consortium.
-
Flum D. R., Belle S. H., King W. C., et al. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med: 2009; 361 5 445 454
-
(2009)
N Engl J Med
, vol.361
, Issue.5
, pp. 445-454
-
-
Flum, D.R.1
Belle, S.H.2
King, W.C.3
-
32
-
-
84890433324
-
Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study
-
LABS Consortium. [Epub ahead of print]
-
Belle S. H., Berk P. D., Chapman W. H., et al. LABS Consortium. Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. Surg Obes Relat Dis: 2013; 9 6 926 935 [Epub ahead of print]
-
(2013)
Surg Obes Relat Dis
, vol.9
, Issue.6
, pp. 926-935
-
-
Belle, S.H.1
Berk, P.D.2
Chapman, W.H.3
-
33
-
-
0029039362
-
Histological grading and staging of chronic hepatitis
-
Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol: 1995; 22 6 696 699
-
(1995)
J Hepatol
, vol.22
, Issue.6
, pp. 696-699
-
-
Ishak, K.1
Baptista, A.2
Bianchi, L.3
-
34
-
-
84868235041
-
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
-
Bedossa P., Poitou C., Veyrie N., et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology: 2012; 56 5 1751 1759
-
(2012)
Hepatology
, vol.56
, Issue.5
, pp. 1751-1759
-
-
Bedossa, P.1
Poitou, C.2
Veyrie, N.3
-
35
-
-
0348047323
-
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
-
DOI 10.1016/j.surg.2003.10.003
-
Kral J. G., Thung S. N., Biron S., et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery: 2004; 135 1 48 58 (Pubitemid 38041453)
-
(2004)
Surgery
, vol.135
, Issue.1
, pp. 48-58
-
-
Kral, J.G.1
Thung, S.N.2
Biron, S.3
Hould, F.-S.4
Lebel, S.5
Marceau, S.6
Simard, S.7
Marceau, P.8
-
36
-
-
24144481800
-
Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women
-
DOI 10.1002/hep.20818
-
Kunde S. S., Lazenby A. J., Clements R. H., Abrams G. A. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology: 2005; 42 3 650 656 (Pubitemid 41233658)
-
(2005)
Hepatology
, vol.42
, Issue.3
, pp. 650-656
-
-
Kunde, S.S.1
Lazenby, A.J.2
Clements, R.H.3
Abrams, G.A.4
-
37
-
-
0037566201
-
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
-
DOI 10.1053/jhep.2003.50229
-
Mofrad P., Contos M. J., Haque M., et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology: 2003; 37 6 1286 1292 (Pubitemid 36667307)
-
(2003)
Hepatology
, vol.37
, Issue.6
, pp. 1286-1292
-
-
Mofrad, P.1
Contos, M.J.2
Haque, M.3
Sargeant, C.4
Fisher, R.A.5
Luketic, V.A.6
Sterling, R.K.7
Shiffman, M.L.8
Stravitz, R.T.9
Sanyal, A.J.10
-
38
-
-
84861543083
-
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
-
Chalasani N., Younossi Z., Lavine J. E., et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology: 2012; 55 6 2005 2023
-
(2012)
Hepatology
, vol.55
, Issue.6
, pp. 2005-2023
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
-
39
-
-
67349271289
-
-
Alrfeti Does Liver Appearance Predict Histopathologic Findings E., Analysis Of Routine Liver Biopsies During Bariatric Surgery P.
-
Dolce C. J., Russo M., Keller J. E., et al. Does liver appearance predict histopathologic findings: prospective analysis of routine liver biopsies during bariatric surgery. Surg Obes Relat Dis: 2009; 5 3 323 328
-
(2009)
Surg Obes Relat Dis
, vol.5
, Issue.3
, pp. 323-328
-
-
Dolce, C.J.1
Russo, M.2
Keller, J.E.3
-
40
-
-
73949150303
-
The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory
-
Teixeira A. R., Bellodi-Privato M., Carvalheira J. B., Pilla V. F., Pareja J. C., D'Albuquerque L. A. The incapacity of the surgeon to identify NASH in bariatric surgery makes biopsy mandatory. Obes Surg: 2009; 19 12 1678 1684
-
(2009)
Obes Surg
, vol.19
, Issue.12
, pp. 1678-1684
-
-
Teixeira, A.R.1
Bellodi-Privato, M.2
Carvalheira, J.B.3
Pilla, V.F.4
Pareja, J.C.5
D'Albuquerque, L.A.6
-
41
-
-
41549129499
-
Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels
-
DOI 10.1001/archinternmed.2007.131
-
Neuschwander-Tetri B. A., Unalp A., Creer M. H.; Nonalcoholic Steatohepatitis Clinical Research Network. Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. Arch Intern Med: 2008; 168 6 663 666 (Pubitemid 351468402)
-
(2008)
Archives of Internal Medicine
, vol.168
, Issue.6
, pp. 663-666
-
-
Neuschwander-Tetri, B.A.1
Unalp, A.2
Creer, M.H.3
-
42
-
-
56649115813
-
Role of fatty acids in the pathogenesis of obesity and fatty liver: Impact of bariatric surgery
-
Verna E. C., Berk P. D. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis: 2008; 28 4 407 426 Diseases
-
(2008)
Semin Liver Dis
, vol.28
, Issue.4
, pp. 407-426
-
-
Verna, E.C.1
Berk, P.D.2
|